Category Archives: Aβ plaque

Researchers reduce Alzheimer’s plaques by targeting glycosylation.


Researchers at the RIKEN-Max Planck Joint Research Center have demonstrated that hallmark symptoms of Alzheimer’s disease can be reduced when sugars are prevented from binding to one of the key enzymes implicated in the disease. The new findings show that abnormal attachment of a particular sugar to the enzyme BACE1 is a critical factor leading to the formation of Aβ

Read more